ALNY vs. SNY
Compare and contrast key facts about Alnylam Pharmaceuticals, Inc. (ALNY) and Sanofi (SNY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ALNY or SNY.
Key characteristics
| ALNY | SNY | |
|---|---|---|
| YTD Return | 46.19% | 1.79% |
| 1Y Return | 72.85% | 10.24% |
| 3Y Return (Ann) | 17.97% | 2.51% |
| 5Y Return (Ann) | 25.40% | 5.24% |
| 10Y Return (Ann) | 12.03% | 4.38% |
| Sharpe Ratio | 1.43 | 0.54 |
| Sortino Ratio | 2.80 | 0.95 |
| Omega Ratio | 1.36 | 1.11 |
| Calmar Ratio | 1.73 | 0.64 |
| Martin Ratio | 4.65 | 1.73 |
| Ulcer Index | 15.08% | 6.56% |
| Daily Std Dev | 49.19% | 20.92% |
| Max Drawdown | -83.58% | -46.65% |
| Current Drawdown | -6.90% | -13.51% |
Fundamentals
| ALNY | SNY | |
|---|---|---|
| Market Cap | $36.09B | $129.58B |
| EPS | -$2.63 | $1.92 |
| PEG Ratio | -0.49 | 0.77 |
| Total Revenue (TTM) | $2.01B | $55.21B |
| Gross Profit (TTM) | $1.79B | $35.86B |
| EBITDA (TTM) | -$146.13M | $16.06B |
Correlation
The correlation between ALNY and SNY is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ALNY vs. SNY - Performance Comparison
In the year-to-date period, ALNY achieves a 46.19% return, which is significantly higher than SNY's 1.79% return. Over the past 10 years, ALNY has outperformed SNY with an annualized return of 12.03%, while SNY has yielded a comparatively lower 4.38% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ALNY vs. SNY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Alnylam Pharmaceuticals, Inc. (ALNY) and Sanofi (SNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ALNY vs. SNY - Dividend Comparison
ALNY has not paid dividends to shareholders, while SNY's dividend yield for the trailing twelve months is around 4.02%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SNY Sanofi | 4.02% | 3.83% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.79% | 4.19% | 3.47% |
Drawdowns
ALNY vs. SNY - Drawdown Comparison
The maximum ALNY drawdown since its inception was -83.58%, which is greater than SNY's maximum drawdown of -46.65%. Use the drawdown chart below to compare losses from any high point for ALNY and SNY. For additional features, visit the drawdowns tool.
Volatility
ALNY vs. SNY - Volatility Comparison
Alnylam Pharmaceuticals, Inc. (ALNY) has a higher volatility of 9.98% compared to Sanofi (SNY) at 6.62%. This indicates that ALNY's price experiences larger fluctuations and is considered to be riskier than SNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ALNY vs. SNY - Financials Comparison
This section allows you to compare key financial metrics between Alnylam Pharmaceuticals, Inc. and Sanofi. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities